Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Summary
The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, predictive of the efficiency of targeted therapies (according to the mutational profile of the cancer), and could allow the study of the mechanisms of resistance under process. In the multiplicity of these blood potential biomarkers joins a permanent evolution of the technological means used to detect them/to quantify, as well as to estimate their clinical utility.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
620
Start Date
2025-10
Completion Date
2035-07
Last Updated
2025-09-19
Healthy Volunteers
No
Conditions
Interventions
Blood sampling C1
Blood samples will be collected at four key time points : * baseline (T1), * first scan assessment (T2), * second scan assessment (T3), * and progression (T4).
Locations (1)
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, France, France